THE EFFECT OF SGLT2 INHIBITOR THERAPY ON THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, [S. l.], v. 86, n. 2, p. 148–150, 2026. Disponível em: https://journalss.org/index.php/obr/article/view/16527. Acesso em: 28 feb. 2026.